From: Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma
NLR ≤ 4
n = 51
NLR > 4
n = 20
P-value
Best response
CR
9 (18%)
0 (0%)
0.086a
PR
3 (6%)
2 (10%)
SD
18 (35%)
5 (25%)
PD/NE
21 (41%)
13 (65%)
Objective response
12 (24%)
0.32a
Clinical benefit
30 (59%)
7 (35%)
0.11b